BMY
Bristol Myers Squibb Co.
$62.86+2.21%
Price
- Market cap
- $128.36 billion
- P/E (TTM)
- 13.82
- EV/EBITDA
- 8.31
- 52W range
- $42.60 – $68.09
- Div yield
- 3.99%
- Volume
- 10.0M
- Sector
- Healthcare
Bristol Myers Squibb Co. (BMY) last closed at $62.86, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for BMY, covered for search and blurred for visitors.
Performance
- 1D-0.91%
- 5D+3.10%
- 1M-1.82%
- 3M-0.63%
- 6M+3.95%
- 1Y+40.22%
- 5Y+7.10%
Financials
Over the latest four reported periods ending June 30, 2026, Bristol Myers Squibb Co. reported revenue of $49.19 billion.
The prior window totaled $47.7 billion, so the latest window is higher than that stretch.
Operating cash flow in the latest window was $12.78 billion.
Free cash flow in the latest window was $11.44 billion.
These amounts are taken from Bristol Myers Squibb Co.'s SEC filings and are a snapshot as of June 30, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.
A few ratios from those statements: Profitability: ROE 14.9% (56 of 100). Leverage: D/E 1.92× (23 of 100). Cash generation: FCF margin 23.3% (47 of 100). Net margin: 25.6% (64 of 100). Liquidity: Current 1.53× (77 of 100).
Cash Flow
Margins
Valuation
- P/E (TTM)
- 13.82
- P/S (TTM)
- 2.61
- EV/EBITDA
- 8.31
Insights
Finorify has not written notes for BMY in this snapshot.
Read the live analysis in Finorify
Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.
Open BMY in Finorify